- $1.25bn
- $1.19bn
- $674.08m
- 95
- 55
- 43
- 69
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 444 | 475 | 568 | 771 | 674 |
Cost of Revenue | |||||
Gross Profit | 115 | 151 | 150 | 199 | 213 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 438 | 420 | 514 | 676 | 572 |
Operating Profit | 6.12 | 54.2 | 54.1 | 94.6 | 102 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.11 | 48.8 | 50.4 | 87.9 | 100 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.33 | 38.5 | 42.9 | 65.8 | 72.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.17 | 38.6 | 42.6 | 65.5 | 72.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.17 | 38.6 | 42.6 | 65.5 | 72.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.216 | 3.45 | 3.91 | 5.96 | 6.53 |
Dividends per Share |